Why the study?
Transcatheter closure of mitral valve leaflet perforation is rarely performed and technically challenging.
Is percutaneous retrograde transcatheter closure of anterior mitral valve leaflet perforation safe and feasible?
Is percutaneous retrograde transcatheter closure of anterior mitral valve leaflet perforation safe and feasible?
Percutaneous retrograde transcatheter closure using an AMPLATZER Duct Occluder II device is a safe and feasible option for treating anterior mitral valve leaflet perforation.
Suggests feasible transcatheter repair for mitral perforation; leaves open need for larger studies before adoption.
Transcatheter closure of mitral valve leaflet perforation is a very rarely performed and a difficult procedure for repairing the defect. Herein, we are the first to report on both the safety and feasibility of percutaneous retrograde transcatheter closure of anterior mitral valve leaflet perforation with an AMPLATZER™ Duct Occluder II (6 mm × 6 mm, ADO II; Abbott Vascular, IL, USA) device in a 19-year-old patient with a severe mitral valve regurgitation following cardiac surgery.
No takes yet. Share an insight, caveat, or question.
Çeliker et al. (2019) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: